
|Articles|February 1, 2004
Prospective study confirms contrast sensitivity benefits of IOL
Eugene, OR-Implantation of the anterior surface modified prolate IOL (Tecnis, Pfizer Ophthalmics) results in improved functional vision for cataract surgery patients compared with a standard spherical IOL, said Mark D. Packer, MD.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
EURETINA 2026: 3 gene therapy programmes for nAMD approaching phase 3 readouts
2
FAQ: What clinicians need to know about OCU410 phase 2 ArMaDa results
3
EURETINA 2026: Real-world evidence on retinal biosimilars
4
EURETINA 2026: Why half-dose PDT leads the treatment of central serous chorioretinopathy
5


















